<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000443024"><TermName>strontium ranelate</TermName><TermPronunciation>(STRON-shee-um RAN-eh-layt)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied in the treatment of osteoporosis in postmenopausal women. Strontium ranelate helps new bone tissue to grow and decreases bone loss. This lowers the risk of bone fractures.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000714632" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;strontium ranelate&quot;" language="en" id="_3"/><MediaLink ref="CDR0000714633" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;ranelato de estroncio&quot;" language="es" id="_4"/><SpanishTermName>ranelato de estroncio</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de la osteoporosis en las mujeres posmenopáusicas. El ranelato de estroncio ayuda a que crezca tejido óseo nuevo y diminuya la pérdida de hueso. Esto disminuye el riesgo de sufrir fracturas en los huesos.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2006-09-10</DateFirstPublished></GlossaryTerm>
